Friday, February 26, 2021

Latest:

Brightfield & Multispectral Fluorescence Imaging and Spectral Unmixing
Laboratory Blender for Research and Development
Multifunctional Container Blenders for Pharmaceutical Production
Proprietary Hydrogel Deposition and Demoulding Manufacturing Processes
Hammer Mills for Pharmaceutical Solids Production

Pharma Industry Review

Events
Companies
Resources
Sectors
DISEASES
Investment
- Stocks
Projects
COVID-19

Deals

Boehringer Ingelheim and Enara Bio join forces to develop new Cancer Immunotherapies

January 18, 2021January 22, 2021 Pharmaceutical Industry Editor vaccine development

Boehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and

Deals DISEASES Immunology

Sanofi to purchase Kymab and add OX40L monoclonal antibody to its pipeline

January 14, 2021January 14, 2021 Pharmaceutical Industry Editor monoclonal antibodies

Sanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting

Deals Neurology

Eli Lilly enters $1 billion agreement to acquire Prevail Therapeutics

December 16, 2020December 16, 2020 Pharmaceutical Industry Editor

Eli Lilly & Co and Prevail Therapeutics announced a definitive agreement for Lilly to acquire Prevail for a total consideration

Deals

PharmaBlock and Ascentage Pharma enter into a strategic partnership

December 14, 2020December 14, 2020 Pharmaceutical Industry Editor

PharmaBlock Sciences, a pioneering service provider throughout the pharmaceutical R&D processes, announced it has entered into a strategic partnership with

COVID-19 Deals DISEASES Infectious Diseases Latest

EC to purchase up to 160 mill doses of Moderna’s COVID-19 vaccine

November 25, 2020December 2, 2020 Pharmaceutical Industry Editor RNA, vaccine development

Moderna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19

COVID-19 Deals DISEASES Infectious Diseases Latest Manufacturing

Pfizer & BioNTech to supply EU with 200 million COVID-19 vaccine doses

November 14, 2020November 16, 2020 Pharmaceutical Industry Editor RNA

Pfizer and BioNTech announced this week that they have reached an agreement with the European Commission to supply 200 million

COVID-19 Deals DISEASES Infectious Diseases Latest

Sanofi & GSK to support COVAX with 200 m adjuvanted recombinant protein-based COVID-19 vaccines

October 31, 2020November 9, 2020 Pharmaceutical Industry Editor Adjuvants, recombinant protein, vaccine development

Sanofi and GSK plan to make available to the Gavi lead COVAX Facility 200 million doses of their adjuvanted recombinant

COVID-19 Deals DISEASES Infectious Diseases Latest

Lilly to supply 300,000 vials of COVID-19 monoclonal antibody to the U.S.

October 30, 2020January 14, 2021 Pharmaceutical Industry Editor antibodies, APIs, monoclonal antibodies, vaccine development

Eli Lilly and Company officially announced on Oct. 28, an initial deal with the U.S. government to supply 300,000 vials

COVID-19 Deals DISEASES Infectious Diseases Latest

Moderna signs agreement to supply Qatar with mRNA COVID-19 vaccine

October 26, 2020October 26, 2020 Pharmaceutical Industry Editor RNA, vaccine development

American biotech Moderna has signed an agreement with the Ministry of Public Health to supply Qatar with its mRNA COVID-19

Cardiovascular Deals Latest Pharma Stocks R&D Vascular Diseases

BMS boosts cardiovascular pipeline with $13.1 Billion MyoKardia buy

October 6, 2020October 18, 2020 Pharmaceutical Industry Editor

Bristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion

← Previous

Ticker Tape by TradingView

Please leave this field empty

DON’T MISS A THING

Be the first to receive the latest news from the pharma industry

We don’t spam! Read our Privacy Policy for more info.

Check your inbox or spam folder to confirm your subscription.

Featured Company

FEATURED
Ectica Technologies

New

Featured

Category: Assays, Drug Discovery and Laboratory Equipment

Next-gen hydrogel-based tools and specialty chemicals Details Products Downloads Videos Press Releases Contact Details Ectica Technologies is an innovative manufacturer and supplier of hydrogel-based tools and specialty chemicals for drug discovery, research, and manufacturing applications in the pharmaceutical, biotech and life sciences industries.Ectica offers modern ready-to-use solutions to advance drug development and R&D programs such as the 3DProSeed™ hydrogel microtitre Read more…

LATEST

Drug Development Immunology Neurology Oncology Preclinical Studies Products R&D

Brightfield & Multispectral Fluorescence Imaging and Spectral Unmixing

February 24, 2021February 24, 2021 Pharmaceutical Industry Editor

The cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of

Manufacturing Products

The cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of

About Us

Pharma Industry Review is here to provide you with the latest news, reviews and insights from the pharmaceutical industry so that you can take your business one step ahead.

About Us

Contact Us
Editorial Standards
Terms & Conditions
Privacy Policy
Users

Useful Links

Client Portal
Advertise
Presentation Portal
Sectors
Projects

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits, according to our Privacy Policy. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

);